Population
Patients with chronic kidney disease (CKD)
Design
Review
Authors
Loading...
Sympathetic modulation merits exploration in CKD hypertension; leaves open whether targeted interventions improve CV outcomes independent of BP.
Highlights the detrimental role of sympathetic overactivity in CKD progression and cardiovascular risk, emphasizing the need for targeted therapies.
Kaur et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: